Equity Incentive Plans - Summary of Restricted Stock Unit and Market-Based Restricted Stock Units Activity (Details) - $ / shares	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Weighted-Average Grant Date Fair Value per Share
Weighted-Average Grant Date Fair Value per Share, Nonvested Outstanding, Granted	$ 5.5	$ 2.7	$ 5.61
Restricted Stock Units (RSUs) \| 2019 Equity Incentive Plan
Restricted Stock Units Outstanding
Restricted Stock Units Outstanding, Nonvested Outstanding, Beginning Balance	10,174,852
Restricted Stock Units Outstanding, Granted	5,300,170
Restricted Stock Units Outstanding, Forfeited	(869,462)
Restricted Stock Units Outstanding, Vested	(3,359,894)
Restricted Stock Units Outstanding, Nonvested Outstanding, Ending Balance	11,245,666	10,174,852
Weighted-Average Grant Date Fair Value per Share
Weighted-Average Grant Date Fair Value per Share, Nonvested Outstanding, Beginning Balance	$ 7.2
Weighted-Average Grant Date Fair Value per Share, Nonvested Outstanding, Granted	8.31	$ 4.03	$ 8.29
Weighted-Average Grant Date Fair Value per Share, Nonvested Outstanding, Forfeited	7.51
Weighted-Average Grant Date Fair Value per Share, Nonvested Outstanding, Vested	8.65
Weighted-Average Grant Date Fair Value per Share, Nonvested Outstanding, Ending Balance	$ 7.26	$ 7.2
Market-Based Restricted Stock Units \| 2019 Equity Incentive Plan
Restricted Stock Units Outstanding
Restricted Stock Units Outstanding, Nonvested Outstanding, Beginning Balance	3,831,114
Restricted Stock Units Outstanding, Granted	2,020,000
Restricted Stock Units Outstanding, Forfeited	(247,117)
Restricted Stock Units Outstanding, Vested	(247,117)
Restricted Stock Units Outstanding, Nonvested Outstanding, Ending Balance	5,356,880	3,831,114
Weighted-Average Grant Date Fair Value per Share
Weighted-Average Grant Date Fair Value per Share, Nonvested Outstanding, Beginning Balance	$ 10.8
Weighted-Average Grant Date Fair Value per Share, Nonvested Outstanding, Granted	13.5
Weighted-Average Grant Date Fair Value per Share, Nonvested Outstanding, Forfeited	18.89
Weighted-Average Grant Date Fair Value per Share, Nonvested Outstanding, Vested	18.89
Weighted-Average Grant Date Fair Value per Share, Nonvested Outstanding, Ending Balance	$ 11.07	$ 10.8

Adaptive Biotechnologies Corp 10-K